IL17A and inflammatory skin disease: This study successfully demonstrates that DHA targets FGFR1 to inhibit IL-17A-induced hyperproliferation and inflammatory response in HaCaT cells, and provides a new idea for the therapeutic study of inflammatory skin diseases such as psoriasis.